Clinical Trials Logo

Stent Related Symptoms clinical trials

View clinical trials related to Stent Related Symptoms.

Filter by:
  • None
  • Page 1

NCT ID: NCT04325880 Recruiting - Ureteral Stent Clinical Trials

Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms

Start date: December 1, 2021
Phase: Phase 3
Study type: Interventional

The primary objective of this prospective, single-centre randomized controlled trial is to assess the efficacy of three different drugs in treatment of ureteral stents related symptoms (Beta 3 adrenergic receptor agonist; Mirabegron 50mg) vs. (Alpha 1 adrenergic receptor antagonist; Tamsulosin 0.4mg) vs. (Anticholinergic; Solifenacin 10 mg) using validated symptoms questionnaires. In addition, adverse events of the utilized medications will be monitored during study period as a secondary objective.